Feature | December 05, 2016

Most Popular DAIC Content in November 2016

TCT 2016, TCT.16, main arena, late breaking trials, transcatheter cardiovascular therapeutics

There were several hot topics that came out of the 2016 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting Oct. 29 - Nov. 2, which made this month's top 20 list, including several videos. Number 4 on the list of content was the result of the EXCEL Trial key TCT late-breaker, which showed stenting is equal in outcomes to surgery for the first time, when using one of the latest generation drug-eluting stents. 

December 5, 2016 — Here is the list of the top 20 most popular pieces of content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of November based on website analytics:  

1. Independent Study Finds Biodegradable Polymer Stents Provide No Clinical Benefit Over Resolute Integrity DES

2. 5 Technologies to Reduce Cath Lab Radiation Exposure

3. Study Deems Transcaval Valve Replacement Pioneered at Henry Ford Hospital Successful

4. Stents, Bypass Surgery Equally Safe and Effective for Many with Left Main Heart Disease

5. Getting a Pacemaker Soon After Heart Valve Replacement Linked with Worse Outcomes

6. VIDEO: Editor’s Choice of the Most Innovative Cardiology Technology at TCT 2016

7. VIDEO: Bioresorbable Stent Failure Modes, Technique, Patient Selection and Future Development

8. Medtronic Receives FDA Approval for Claria MRI Quad Cardiac Resynchronization Therapy Defibrillator

9. VIDEO: The State of TAVR in 2016

10. Henry Ford Hospital Cardiologist Performs Pioneering Laser Mitral Valve Treatment

11. New Smartphone App Detects Heart Attacks

12. Study Concludes Very Early Percutaneous Coronary Intervention Following Fibrinolysis Safe

13. St. Jude Medical Recalls ICDs and CRT-D Due to Premature Battery Depletion

14. Study Finds STEMI Post-conditioning is Not as Beneficial as Previously Believed

15. VIDEO: Technologies to Reduce Heart Failure Readmissions

16. Understanding the Design and Function of Guidewire Technology

17. VIDEO: The Basics of Interventional Guidewire Design and Function

18. Pre-emptively Stenting Vulnerable Plaque Found to be Safe

19. Bioresorbable Polymer Metallic Stents Did Not Improve Outcomes Compared to Durable Polymer Stents

20. First Clinical Data of Medtronic Drug-Filled Stent Show Positive Outcomes

 

Read the related content “Most Popular DAIC Content in October 2016.”
 

Related Content

Teleflex Launches Next-Generation Sympro Elite and Expro Elite Snares
Technology | Cath Lab | February 07, 2018
Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U.S. commercial launch...
SCAI Advocacy Committee Highlights Reimbursement Reform Efforts in 2017
News | Cath Lab | January 30, 2018
The Society for Cardiovascular Angiography and Interventions (SCAI) highlighted the efforts of its Advocacy Committee...
IAC Releases Cardiovascular Catheterization Accreditation Program
News | Cath Lab | January 25, 2018
January 25, 2018 – The Intersocietal Accreditation Commission (IAC) announced the release of its Cardiovascular Cathe
Videos | Cath Lab | January 04, 2018
Bernadette Speiser, BSN, MSN, CCRN, RCIS, a cardiac cath/EP nurse at Palo Alto Veterans Hospital, Palo Alto, Calif.,
FDA Initiates Class I Recall of Sterilmed Reprocessed Agilis Steerable Introducer Sheath
News | Cath Lab | January 04, 2018
The U.S. Food and Drug Administration (FDA) announced a Class I recall of Sterilmed’s Agilis Steerable Introducer...
The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA atherectomy system. Athar Ansari, M.D.

The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA system. 

Feature | Cath Lab | November 24, 2017 | Athar Ansari, M.D., FACC
As debates about the current state and future of healthcare rage in Congress, the media and healthcare settings acros
Videos | Cath Lab | November 08, 2017
Juan Granada, M.D., Cardiovascular Research Foundation president and chief executive officer, shares his insights on
Results of the ORBITA study found no difference in exercise time after six weeks in patients with stable angina who received percutaneous coronary intervention (PCI) versus a placebo treatment. TCT 2017
Feature | Cath Lab | November 06, 2017
November 6, 2017 – Results from ORBITA, a prospective multi-center randomized blinded placebo-controlled study, found
Culprit Lesion-Only PCI Improves Outcomes for Cardiogenic Shock Patients Compared to Multivessel PCI
News | Cath Lab | November 01, 2017
November 1, 2017 — Results from the prospective, randomized, multicenter CULPRIT-SHOCK trial found an initial strateg
Overlay Init